Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
EPA CPDat observed this chemical in 5572 composition records across product categories including Construction and building materials, Furniture and furnishings, Raw materials.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of PARAFFIN in our catalog (epa_cpdat).
Products
5,572
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Canonical allergen markers detected on this ingredient. Each row is derived from the ingredient’s name or synonyms matching a known allergen class — useful when scanning a label for a specific allergy context.
Source: chemindex_name_match
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 5572 composition records across product categories including Construction and building materials, Furniture and furnishings, Raw materials. EPA CPDat classifies this chemical for functional uses including Viscosity modifier, Softener and conditioner, Abrasive.
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 100 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Potency: 0.7 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.07 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 0.2 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 321 mg
US
FDA
Route: RECTAL; Dosage form: OINTMENT; Maximum daily exposure: 38 mg
US
FDA
Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 94.93 %w/w
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 300 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 2860 mg
US
FDA
FDA NDC lists this ingredient in 8 active drug products and 9 total products.
US
FDA
openFDA substance registry classifies this ingredient as structurallydiverse.
US
FDA
openFDA substance registry classifies this ingredient as concept.